Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Melatonin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Melatonin 2mg modified-release tablets
0401010ADAAAAAA
|
Melatonin | Melatonin | Central Nervous System | 142,754 |
|
Circadin 2mg modified-release tablets
0401010ADBBAAAA
|
Circadin | Melatonin | Central Nervous System | 57,208 |
|
Melatonin 1mg/ml oral solution sugar free
0401010ADAACZCZ
|
Melatonin | Melatonin | Central Nervous System | 28,007 |
|
Melatonin 2mg tablets
0401010ADAABKBK
|
Melatonin | Melatonin | Central Nervous System | 19,094 |
|
Slenyto 1mg modified-release tablets
0401010ADBDAACU
|
Slenyto | Melatonin | Central Nervous System | 10,192 |
|
Melatonin 3mg tablets
0401010ADAACYCY
|
Melatonin | Melatonin | Central Nervous System | 9,854 |
|
Slenyto 5mg modified-release tablets
0401010ADBDABCV
|
Slenyto | Melatonin | Central Nervous System | 8,883 |
|
Melatonin 2mg capsules
0401010ADAAAEAE
|
Melatonin | Melatonin | Central Nervous System | 8,122 |
|
Adaflex 2mg tablets
0401010ADBGABBK
|
Adaflex | Melatonin | Central Nervous System | 6,527 |
|
Melatonin 4mg tablets
0401010ADAACPCP
|
Melatonin | Melatonin | Central Nervous System | 5,908 |
|
Melatonin 1mg modified-release tablets
0401010ADAACUCU
|
Melatonin | Melatonin | Central Nervous System | 5,225 |
|
Melatonin 3mg capsules
0401010ADAABRBR
|
Melatonin | Melatonin | Central Nervous System | 4,079 |
|
Ceyesto 1mg/ml oral solution
0401010ADBFABCZ
|
Ceyesto | Melatonin | Central Nervous System | 3,477 |
|
Melatonin 5mg modified-release tablets
0401010ADAACVCV
|
Melatonin | Melatonin | Central Nervous System | 3,372 |
|
Melatonin 2mg/5ml oral solution
0401010ADAABYBY
|
Melatonin | Melatonin | Central Nervous System | 2,863 |
|
Adaflex 3mg tablets
0401010ADBGACCY
|
Adaflex | Melatonin | Central Nervous System | 2,462 |
|
Melatonin 1mg tablets
0401010ADAAAIAI
|
Melatonin | Melatonin | Central Nervous System | 2,377 |
|
Melatonin 5mg tablets
0401010ADAABLBL
|
Melatonin | Melatonin | Central Nervous System | 2,339 |
|
Adaflex 4mg tablets
0401010ADBGADCP
|
Adaflex | Melatonin | Central Nervous System | 2,117 |
|
Adaflex 5mg tablets
0401010ADBGAEBL
|
Adaflex | Melatonin | Central Nervous System | 1,681 |
|
Adaflex 1mg tablets
0401010ADBGAAAI
|
Adaflex | Melatonin | Central Nervous System | 1,509 |
|
Melatonin 5mg capsules
0401010ADAABSBS
|
Melatonin | Melatonin | Central Nervous System | 1,305 |
|
Melatonin 10mg/5ml oral suspension
0401010ADAACECE
|
Melatonin | Melatonin | Central Nervous System | 898 |
|
Syncrodin 3mg tablets
0401010ADBEAACY
|
Syncrodin | Melatonin | Central Nervous System | 840 |
|
Ceyesto 3mg tablets
0401010ADBFAACY
|
Ceyesto | Melatonin | Central Nervous System | 831 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.